Home  Cancer Highlights
|
IntroductionCancer Highlights is a publication series covering key topics in the field of oncology. It focuses on R&D and business development. Cancer Highlights has 14 publications in total, covering three main topics updated over an 18 months cycle.
Each publication is written by BioSeeker's oncology professionals who have years of experience analyzing cancer R&D and business development. |  | BioSeeker's knowledge base in oncology includes more than 1,000 cancer R&D companies and close to 3,000 drugs, from drug discovery to marketed. Cancer Highlights is designed by BioSeeker to assist and enhance our readers' business insights and intelligence in oncology. These reports will assist you to: | - improve competitor analysis
- outline R&D alignments
- identify and follow trends and future insights
- identify key breakthroughs important for your company
- track cutting edge companies, therapies and new technologies
- save significant time in identifying your partners & competitors
|
Pricing ModelWe at BioSeeker would like to invite you to get more market research for less of your budget. Our pricing model for Cancer Highlights is very competitive and is a worthy investment for any company, from small firms to big pharma. Read more about our licenses here. You will save a minimum of 75% to be a subscriber compared to single issue price for these publications. | 
*One subscription cycle (Approx. 1 year) includes 8 consecutive publications.
Back issues of any Cancer Highlights publication is available at only 780 EUR (PDF) for subscribers.
|
To Subscribe and Make a Renewal To start a one year subscription or make a renewal press this link and choose Quantity 1 for single user license, Quantity 2 for site license and Quantity 3 for global license. You may select your first Cancer Highlights report by leaving us a note with your order. Default is the most present Cancer Highlights published. One subscription cycle (Approx. 1 year) includes 8 consecutive publications. Your subscription will end after 8 publications and you have the option to make a renewal. | |
Available Cancer Highlights ReportsWhen you purchase a single issue of Cancer Highlights, you may subtract your first investment from the subscription price when you upgrade to a subscription, within a month from the date of purchase. 
Cancer Vaccines: Aim and Shoot, No 1 Vol 8 # 2008
Cancer Antibodies: Competitive Positioning for Success, No 2 Vol 8 #2008
Currently Druggable in Breast Cancer: A Drug Target Competitive Analysis, No 3 Vol 8 #2008 
Global Cancer Focus Company Directory, No 1 Vol 7 #2007
Antibody Drug Target Atlas in Oncology, No 2 Vol 7 #2007
Melanoma - Targeted Therapeutics, No 3 Vol 7 #2007
Decoding Big Pharma's R&D Strategy in Oncology, No 4 Vol 7 #2007
The Drug Target Atlas of Protein Kinase Inhibitors in Oncology, No 5 Vol 7 #2007
The Drug Target Atlas of Apoptopic Drugs in Oncology, No 6 Vol 7 #2008
Target Atlas: Competitive Insights to Anti-Angiogenic Drug R&D in Oncology, No 7 Vol 7 #2008
The Deployment of Antibody Technologies for the Advancement of Cancer Therapeutics, No 8 Vol 7 #2008 
Current and Future Therapies for Lung Cancer - A Therapeutic & Competitive Insight, No 1 Vol 6 #2006
Lymphoma - A Therapeutic & Competitive Insight, No 2 Vol 6 #2006
Competitive Outlook on Non-Antibody Based Cancer Vaccines, No 3 Vol 6 #2006
Leukemia - A Therapeutic & Competitive Insight, No 4 Vol 6 #2006
Competitive Outlook on Antiangiogenesis and Vascular Targeting in Oncology, No 5 Vol 6 #2006
Competitive Outlook on Apoptosis in Oncology, No 6 Vol 6 #2006
Prostate Cancer - Therapeutic & Competitive Insights, No 7 Vol 6 #2006
Breast Cancer - Therapeutic & Competitive Insights, No 8 Vol 6 #2006
Global Pipeline Review & Analysis of Hematological Malignancies, No 9 Vol 6 #2006
Targeted Therapeutics in Non-Small Cell Lung Cancer, No 10 Vol 6 #2007 
Cancer Vaccine Fantasy or Future?, No 1 Vol 5 #2005
Vascular Targeting Agents: Emerging Competitors, No 2 Vol 5 #2005
Breast Cancer: The Latest R&D Trends , No 3 Vol 5 #2005
Apoptosis: Promise or deception, No 4 Vol 5 #2005
Melanoma Therapeutics: Which Strategy Will Take Us There?, No 5 Vol 5 #2005
Current and Future Therapies for Colorectal Cancer - A Therapeutic & Competitive Insight, No 6 Vol 5 #2005
The Commercial Success of Cancer Therapeutic Antibodies - The Formation of a Second Wave, No 7 Vol 5 #2005
Superficial Bladder Cancer - Current Management and Future Trends, No 8 Vol 5 #2005
New Concepts in Cancer Therapeutics, No 9 Vol 5 #2006
Strategic Outlook on Protein Kinase Inhibitors in Oncology, No 10 Vol 5 #2006 |
|
|
|
